In an interview for the Norwegian TV2, Nina Langeland and Rebecca Cox explained the results of a new study conducted by the University of Bergen and Haukeland University Hospital on long COVID. – As many as 46 percent of the COVID patients in our study report long-term effects, and that is high, said Nina Langeland,…
Read more
We have published a case report about an immunocompromised patient (treated with Rituximab against multiple sclerosis) with longterm fever, hypoxia and low-grade SARS-CoV-2 infection. The patient was hospitalized three times over a period of 102 days. The case report describes the clinical and diagnostic challenges and the interdisciplinary team work needed to distinguish hyperinflammation from…
Read more
Although most people who undergo SARS-CoV-2 infection recover, a significant proportion suffer long-term symptoms and late sequelae, also known as long COVID. We investigated long COVID symptoms in 233 people with a mild to moderate course of acute COVID-19. Our study showed that 46% of COVID-19 infected participants had one or more long COVID symptoms…
Read more
An educational video for kids from the VACCELERATE project about the importance and value of clinical trials is now available in several languages (English, German, Greek and Spanish). Listen to what the fairy “Well-being” has to say: https://youtube.com/watch?v=YZqPSe-YyxY
The VACCELERATE clinical research network that the Influenza Centre is engaged in has issued its first newsletter. You can access the full version on the VACCELERATE website: https://vaccelerate.eu/newsletters/ Check it out!
Our colleague Sarah Larteley Lartey Jalloh successfully defended her PhD thesis entitled “Humoral and cellular immune responses after pandemic and seasonal influenza vaccination in humans” on June 22, 2022. Her work was supervised by the Head of the Influenza Centre – Professor Rebecca Cox, and co-supervisors – Åsne Jul-Larsen and Fan Zhou. Sarah’s trial lecture…
Read more
50 people from Bergen who are 75 years old or older will receive the fourth dose of the mRNA vaccine against COVID-19, as part of the EU-COVAT AGED study connected to the VACCELERATE project aiming to investigate how the immune system responds to one more booster dose of the vaccine. 20 patients have already been…
Read more
Sarah Larteley Lartey Jalloh who is a member of our Influenza group will defend her PhD thesis on “Humoral and cellular immune responses after pandemic and seasonal influenza vaccination in humans” on June 22, 2022. Her opponents will be Professor Hideki Ueno (Kyoto University, Japan) and Researcher Ranveig Braathen (University of Oslo, Norway), with Associate…
Read more
English